SCOTUS Urged to Deny FDA Relief in Abortion Pill Fight

Sept. 8, 2020, 5:22 PM

The U.S. Supreme Court should let stand an order requiring the Food and Drug Administration to allow women to get a medication used to induce abortions by mail or delivery during the Covid-19 public health emergency, doctors’ groups told the high court Tuesday.

Various women’s health organizations, including the American College of Obstetricians and Gynecologists, urged the nation’s top court to deny FDA’s application for a stay of a district court decision that temporarily blocked it from enforcing an in-person dispensing requirement for the drug mifepristone.

Mifepristone, also known as Mifeprex, is one of a two-drug regime used to end ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.